Browse the evidence

Chronic hyperglycemia induces mitochondrial ROS production and ER stress, creating a vicious cycle that impairs pancreatic beta-cell function and insulin secretion, leading to Type 2 Diabetes.

To protect your beta-cells, focus on preventing chronic high blood sugar. The paper suggests that keeping glucose levels stable reduces the oxidative stress that damages the cells responsible for making insulin. This means prioritizing a diet that prevents glucose spikes and supports mitochondrial health.

Artificial intelligence techniques, including fuzzy logic, neural networks, and reinforcement learning, are effective tools for automating blood glucose control and prediction in diabetes management, improving glycemic outcomes and reducing hypoglycemia risk compared to traditional methods or manual management.

For patients using insulin pumps or continuous glucose monitors (CGM), AI-driven 'artificial pancreas' systems can automatically adjust insulin delivery based on real-time glucose readings. This technology has been shown in multiple studies to improve blood sugar control and reduce dangerous low-blood-sugar events, particularly at night, compared to standard pump therapy. Patients should consult their endocrinologist about AI-integrated devices if they struggle with manual dose calculations or frequent hypoglycemia.

Premenopausal women are protected from developing NAFLD due to estrogen-mediated partitioning of fatty acids toward ketone body production and sex-specific browning of white adipose tissue, whereas postmenopausal estrogen deficiency facilitates massive hepatic steatosis and fibrotic progression.

For women, reproductive status is a critical factor in liver health. Before menopause, estrogen helps protect the liver by directing fat away from storage in the liver and towards energy use (ketones). After menopause, this protection vanishes, significantly increasing the risk of fatty liver and scarring, even if weight doesn't change drastically. Maintaining metabolic health becomes even more crucial post-menopause to counteract this hormonal shift.

Postmenopausal women have a higher prevalence of NAFLD than premenopausal women, and this risk is independently associated with menopause status even after adjusting for metabolic factors in some studies.

After menopause, your risk of fatty liver disease increases significantly, even if you maintain a healthy weight. This is largely due to the loss of estrogen. Regular liver health monitoring is recommended for postmenopausal women.

Stimulating de novo adipogenesis (adipocyte hyperplasia) in visceral white adipose tissue during caloric excess drives healthy tissue remodeling, maintaining insulin sensitivity and preventing metabolic syndrome.

Focus on where your body stores fat and how it handles it, not just the scale. Visceral fat accumulation and inability to create new fat cells (hyperplasia) are key drivers of metabolic disease. While you cannot directly 'choose' where fat goes, maintaining metabolic health through exercise and diet supports healthy adipose function. Avoid extreme caloric deficits that may overwhelm adipose expandability, leading to ectopic fat storage in organs.

Fibro-inflammatory progenitors (FIPs) in adipose tissue are anti-adipogenic and promote inflammation and fibrosis, contributing to unhealthy adipose remodeling.

Chronic inflammation in fat tissue can be driven by specific cell types (FIPs) that block healthy fat storage. Managing inflammation through diet and exercise may help reduce the activity of these anti-adipogenic cells, allowing for healthier fat tissue expansion.

Administration of the intestine-restricted FXR agonist fexaramine (FEX) improves glucose tolerance and promotes adipose tissue browning in mice by reshaping gut microbiota to increase lithocholic acid (LCA) production, which activates TGR5/GLP-1 signaling.

This research suggests that specific bile acid signaling, influenced by gut bacteria, plays a key role in how your body handles sugar and fat storage. While this study used a specific drug (fexaramine) in mice, it highlights the importance of gut health in metabolic regulation. For now, there is no direct human supplement equivalent, but maintaining a diverse gut microbiome through diet is a logical step to support these natural pathways.

High-intensity interval exercise increases cerebral angiogenesis and VEGFA levels via the lactate receptor HCAR1, a mechanism absent in skeletal muscle.

To maximize brain blood vessel growth, you likely need to exercise at high intensities that elevate blood lactate levels, as this triggers a specific receptor (HCAR1) that low-intensity exercise may not sufficiently activate.

Estrogen deficiency during menopause leads to dysregulated lipid metabolism, characterized by increased LDL-C, increased triglycerides, and altered HDL subfractions, thereby increasing cardiovascular disease risk.

Understand that the drop in estrogen after menopause naturally raises your LDL cholesterol and triglycerides while lowering protective HDL. This increases your risk of heart disease. Managing this through diet (healthy fats, fiber) and potentially medical intervention is crucial for long-term heart health.

Androgen excess drives metabolic dysfunction in PCOS by promoting visceral adiposity, inducing insulin resistance through adipocyte hypertrophy and reduced adiponectin, and suppressing brown adipose tissue thermogenesis.

For women with PCOS, metabolic issues like insulin resistance and visceral fat accumulation are strongly linked to high androgen levels, not just diet. Treating the hormonal imbalance (e.g., via anti-androgens or insulin-sensitizers) may be necessary to address metabolic health, as lifestyle changes alone may be insufficient if androgen excess persists.

Insulin resistance in PCOS is characterized by selective ovarian insulin resistance (hyper-sensitivity) alongside peripheral resistance, which exacerbates androgen production.

Standard insulin-sensitizing treatments (like metformin) can help lower androgens by reducing insulin levels, which in turn reduces the ovarian stimulation of androgen production.

Lean NAFLD, defined as fatty liver in non-obese individuals, is a significant subset of NAFLD (7-20%) and is associated with insulin resistance and metabolic dysfunction despite normal BMI.

You do not need to be overweight to develop fatty liver. Lean NAFLD affects 7-20% of NAFLD cases and is linked to insulin resistance and metabolic issues. If you have fatty liver, focus on metabolic health markers like blood sugar and insulin sensitivity, not just your weight.

Acute exercise induces mitophagy in skeletal muscle via an AMPK-dependent phosphorylation of Ulk1 at Serine 555, which is required for targeting damaged mitochondria to lysosomes.

Regular exercise triggers a specific cellular cleanup process (mitophagy) that removes damaged mitochondria. This process is driven by the AMPK-Ulk1 signaling pathway. To ensure this cleanup happens, consistent aerobic exercise is required to activate AMPK, which then phosphorylates Ulk1 to target damaged organelles for degradation.

AMPK is required for exercise-induced mitophagy, as blocking AMPK activity abolishes the increase in mitophagic markers (pure red puncta) following exercise.

If your AMPK pathway is impaired (e.g., due to metabolic disease or specific genetic factors), your body may fail to perform the necessary cleanup of damaged mitochondria after exercise, potentially blunting long-term health benefits.

Ulk1 is required for the targeting of mitochondria to lysosomes during exercise-induced mitophagy, but is not required for lysosomal biogenesis itself.

Ulk1 acts as a specific tagger that directs damaged mitochondria to lysosomes for destruction. Without Ulk1, the cell may still produce more lysosomes, but it fails to effectively target and degrade the damaged mitochondria.

Amino acid availability, specifically leucine and arginine, regulates cellular protein synthesis and autophagy via the mTORC1 signaling pathway, where depletion inactivates mTORC1 to trigger autophagy and reduce protein biosynthesis.

To maximize muscle protein synthesis, ensure your diet provides sufficient leucine and arginine to activate the mTORC1 pathway. If these amino acids are depleted, your body shifts to breaking down its own proteins via autophagy. This means the quality and specific amino acid profile of your protein intake matter as much as the total amount.

In Type 2 Diabetes (T2D), beta cell functional impairment is an early predictor of disease progression, often preceding significant loss of beta cell mass.

In T2D, restoring beta cell function (e.g., through weight loss or bariatric surgery) can reverse diabetes rapidly, often before any significant change in beta cell mass occurs. Focus on functional recovery.

Pioglitazone and Vitamin E are beneficial pharmacological interventions for non-diabetic NASH patients, and Pioglitazone improves fibrosis in diabetic patients.

For non-diabetic NASH, Pioglitazone or Vitamin E may be beneficial. For diabetic patients, Pioglitazone has been shown to reverse NASH and improve fibrosis. Consult a physician for prescription options.

The TyG-BMI index (Triglyceride Glucose index multiplied by Body Mass Index) is a superior predictor of insulin resistance compared to TyG index alone, TyG-WC, and TyG-WHtR in Korean adults.

If you are concerned about insulin resistance, ask your doctor for a fasting glucose and triglyceride test. You can calculate the TyG-BMI index yourself using your BMI. This combined metric is a highly accurate, low-cost way to screen for metabolic risk without needing complex or invasive procedures like a glucose clamp.

In aged muscle, mTORC1 is hyperphosphorylated but fails to induce protein synthesis effectively, leading to anabolic resistance and contributing to sarcopenia.

As you age, your muscles become 'anabolically resistant,' meaning standard training might not trigger muscle growth as efficiently. Your mTOR pathway may be 'stuck' in a state that doesn't effectively build protein. To counter this, older adults may need to focus on high-intensity resistance training and adequate protein intake to overcome this resistance and maintain muscle mass.

Histidine supplementation is inappropriate for patients with liver disease due to the risk of hepatic enlargement and increased blood ammonia and glutamine levels.

If you have liver disease, do not take histidine supplements. The paper indicates this can cause your liver to enlarge and increase toxic ammonia levels in your blood. Stick to dietary sources unless advised otherwise by your doctor.

Myostatin inhibition is a potential therapeutic target for muscle atrophy, but current clinical trials have largely failed to increase muscle strength in patients.

Do not expect myostatin-inhibiting supplements or drugs to build muscle strength currently. Clinical trials have failed to show benefits. Focus on resistance training, which naturally modulates these pathways effectively.

Sirtuin levels decrease with age in various tissues, and this decrease is associated with increased DNA damage, oxidative stress, and frailty.

Sirtuin levels naturally decline with age, contributing to frailty and DNA damage. However, lifestyle interventions like calorie restriction and exercise can help maintain or increase sirtuin levels, supporting healthspan.

The nuclear receptor NR4A3 is a critical regulator of exercise-induced metabolic responses, including glucose uptake and mitochondrial function, as its silencing ablates these benefits in human muscle cells.

NR4A3 is a key gene that helps muscles respond to exercise by improving glucose uptake and mitochondrial function. While you cannot directly 'dose' this gene, regular exercise upregulates it, thereby enhancing metabolic health.